潤啤(00291.HK)擬投資景芝全資附屬 進軍中國白酒業務
華潤啤酒(00291.HK)公布,董事會已議決,擬透過投資於一間位於山東省歷史悠久的著名釀酒公司的旗下業務,進軍中國白酒業務。
於2021年8月26日(今日),潤啤附屬酒業控股與目標公司山東景芝白酒及山東景芝酒業(景芝)就擬透過注資方式投資於山東景芝白酒訂立協議。目標公司現時是景芝全資附屬。
投資事項的確實金額會在參考將對山東景芝白酒所進行的估值後落實。預期於投資事項完成後,山東景芝白酒將不會成為潤啤的附屬公司。山東景芝白酒將主要從事在中國釀造、分銷及推廣白酒的業務,而預期於投資事項完成後, 將成為景芝旗下唯一的白酒業務營運主體。
董事會指,投資事項為一個意義重大的里程碑,意味著集團進軍中國白酒市場,此舉將有利於潛在的後續業務發展以及產品組合及收入來源多元化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.